thymoquinone has been researched along with Experimental Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, I; Al Fayi, M; Chandramoorthy, HC; Dera, AA; Rajagopalan, P | 1 |
| Ebeid, EM; El-Ashmawy, NE; Khedr, EG; Mosalam, EM; Salem, ML; Zidan, AA | 1 |
| Cha, HJ; Choi, YH; Heo, J; Jeong, MS; Jun, M; Kim, MH; Kim, SJ; Kim, WT; Lee, HH; Lee, SR; Leem, SH; Mun, JY; Roh, YG | 1 |
| Rajalingam, K; Rajkamal, G; Sugunadevi, G; Suresh, K; Vijayaanand, MA | 1 |
| al-Bekairi, AM; al-Sawaf, HA; al-Shabanah, OA; al-Sohaibani, MO; Badary, OA; Nagi, MN | 1 |
| Badary, OA | 1 |
6 other study(ies) available for thymoquinone and Experimental Neoplasms
| Article | Year |
|---|---|
Indirubin-3-monoxime and thymoquinone exhibit synergistic efficacy as therapeutic combination in in-vitro and in-vivo models of Lung cancer.
Topics: A549 Cells; Animals; Antineoplastic Agents; Apoptosis; Benzoquinones; Cell Cycle; Cell Line; Cell Proliferation; Disease Models, Animal; Drug Combinations; Drug Screening Assays, Antitumor; Female; Humans; In Vitro Techniques; Indoles; Lung Neoplasms; Mice; Mice, Nude; Models, Biological; Neoplasms, Experimental; Oximes | 2020 |
Loading of doxorubicin and thymoquinone with F2 gel nanofibers improves the antitumor activity and ameliorates doxorubicin-associated nephrotoxicity.
Topics: Acetylglucosamine; Animals; Antineoplastic Agents; Antioxidants; Apoptosis; Benzoquinones; Biomarkers; Caspase 3; Cell Survival; Doxorubicin; Drug Delivery Systems; Female; Hep G2 Cells; Humans; Kidney; Liver Neoplasms; MCF-7 Cells; Mice; Nanofibers; Neoplasms, Experimental; Oxidative Stress; Particle Size | 2018 |
Thymoquinone-Induced Tristetraprolin Inhibits Tumor Growth and Metastasis through Destabilization of MUC4 mRNA.
Topics: Animals; Antineoplastic Agents; Benzoquinones; Cell Line; Cell Movement; Cell Proliferation; Female; Humans; MCF-7 Cells; Mice; Mice, Inbred C57BL; Mucin-4; Neoplasms, Experimental; RNA Stability; RNA, Messenger; Tristetraprolin | 2019 |
Evaluation of chemopreventive effects of Thymoquinone on cell surface glycoconjugates and cytokeratin expression during DMBA induced hamster buccal pouch carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Benzoquinones; Carcinogens; Carcinoma, Squamous Cell; Chemoprevention; Cricetinae; Drug Evaluation, Preclinical; Glycoconjugates; Keratins; Male; Membrane Glycoproteins; Mesocricetus; Mouth Neoplasms; Neoplasms, Experimental | 2010 |
Thymoquinone ameliorates the nephrotoxicity induced by cisplatin in rodents and potentiates its antitumor activity.
Topics: Animals; Antineoplastic Agents; Benzoquinones; Cisplatin; Drug Interactions; Female; Kidney; Male; Mice; Neoplasms, Experimental; Rats; Rats, Wistar | 1997 |
Thymoquinone attenuates ifosfamide-induced Fanconi syndrome in rats and enhances its antitumor activity in mice.
Topics: Administration, Oral; Analysis of Variance; Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Benzoquinones; Fanconi Syndrome; Female; Ifosfamide; Injections, Intraperitoneal; Male; Mice; Neoplasms, Experimental; Rats; Rats, Wistar | 1999 |